Filing Details

Accession Number:
0000899243-22-014109
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-04-06 16:38:52
Reporting Period:
2022-04-04
Accepted Time:
2022-04-06 16:38:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1527599 Synlogic Inc. SYBX Pharmaceutical Preparations (2834) 261824804
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1820122 Antoine Awad C/O Synlogic, Inc.
301 Binney Street, Suite 402
Cambridge MA 02142
Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-04-04 2,650 $2.45 81,170 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Represents the number of shares sold by the reporting person on April 4, 2022 to cover the tax liability in connection with the vesting of two restricted stock awards, vesting on April 1, 2022, that were granted in 2020 and 2021. The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 23, 2021.
  2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.40 to $2.45, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.